SOURCE: EastPharma Ltd

December 03, 2007 03:38 ET

EastPharma's subsidiary Deva Holding A.S. - Nine months 2007 unaudited results

LONDON, UK--(Marketwire - December 3, 2007) -



EastPharma's subsidiary Deva Holding A.S. - Nine months 2007 unaudited results

London, 3 December 2007 - EastPharma's subsidiary Deva Holdings A.S. published today its unaudited results for the nine months ended 30 September 2007, as announced to the Administration of the Istanbul Stock Exchange in accordance with the Capital Markets Board's communiqué serial VIII, No:39.

Deva Holding has exhibited strong growth compared to the previous same period and has moved firmly into profitability. EastPharma will be announcing its consolidated and audited nine month 2007 results encompassing Deva Holding and Saba on or shortly before 20th December 2007.

A summary of the financial results for Deva Holding for the period 1.01.2007 to 30.09.2007 is provided below.



                   9M 2007 (TRY)   9M 2006 (TRY)   Change
Revenues           216,385,109     143,140,337     +51.2%
Gross Profit       103,786,039     63,078,547      +64.5%
Operating Profit   29,632,280      (8,790,321)     n/a
Profit before tax  110,651,981     (36,869,635)    n/a

Net Profit         99,483,035      (36,059,808)    n/a
Earnings per share 0.0359          (0.0143)        n/a

Detailed financial statements of Deva Holding are provided in the Attachment:

http://hugin.info/138031/R/1172460/231738.pdf

For further information, please contact:
EastPharma Limited
Idil Bora - Investor Relations
Tel.: + 90 (212) 6929326





Copyright © Hugin ASA 2007. All rights reserved.

Contact Information